CX3CR1 and Alzheimer disease: Our research demonstrated a significant reduction in Cx3cr1-labeled microglia in AD model mice (APP_NL_F_G) when compared to control conditions, whereas CX3CR1-labeled microglia remained stable in both normal elderly humans and AD patients.